IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL (Q24338171)

positive regulation of tumor necrosis factor (ligand) superfamily member 11 production

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Naoyuki Kamatani

9

0 references

author name string

Shigeru Kotake

1

0 references

Yuki Nanke

2

0 references

Makio Mogi

3

0 references

Manabu Kawamoto

4

0 references

Takefumi Furuya

5

0 references

Toru Yago

6

0 references

Tsuyoshi Kobashigawa

7

0 references

Akifumi Togari

European Journal of Immunology

8

0 references

language of work or name

English

0 references

publication date

November 2005

0 references

published in

0 references

volume

35

0 references

issue

11

0 references

page(s)

3353-63

0 references

cites work

Immunostimulatory DNA sequences influence the course of adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Activated T lymphocytes support osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

How important are T cells in chronic rheumatoid synovitis?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

T cells and related cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Biphasic effect of interferon-gamma in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Susceptibility to collagen-induced arthritis: cytokine-mediated regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Long-term treatment of osteopetrosis with recombinant human interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Recombinant human interferon gamma therapy for osteopetrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Primary hyperparathyroidism in elderly patients with hip fracture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Effects of activated T cells on osteoclastogenesis depend on how they are activated

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021

Osteoclast differentiation factor in human osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526141

7 January 2021